Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
May 2, 2022
Document Date
Jun 14, 2022
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.